WPA
IDXX icon

West Paces Advisors’s Idexx Laboratories IDXX Stock Holding History

West Paces Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.63K Buy
+5
New +$2.8K ﹤0.01% 550
2024
Q1 		– Sell
-1
Closed -$555 – 632
2023
Q4 		$555 Buy
+1
New +$469 ﹤0.01% 551

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

West Paces Advisors's IDXX Position: Q2 2026 in Review

West Paces Advisors opened a new position in Idexx Laboratories (IDXX) in Q2 2026: 5 shares worth $2.63K. The stake represents ﹤0.01% of the portfolio and ranks #550 among its holdings. This is a return to the name: West Paces Advisors previously reported a position in IDXX as recently as Q4 2023.

West Paces Advisors first reported a position in IDXX in Q4 2023 and has held it in 2 quarters since. 1,306 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • West Paces Advisors held 5 shares of Idexx Laboratories worth $2.63K as of Q2 2026.
  • Idexx Laboratories was a new West Paces Advisors position in Q2 2026.
  • Idexx Laboratories made up ﹤0.01% of West Paces Advisors's portfolio in Q2 2026, its #550 holding.
  • West Paces Advisors first reported a position in Idexx Laboratories in Q4 2023 and has held it in 2 quarters since.
  • 1,306 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on West Paces Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.